E-Tele offers medical weight loss program that's physician lead to help you achieve your weight loss goals

We are here to serve you on your schedule. We deliver Simple, convenient and private solutions to fit your needs. Follow the links to fill out an E-Consult  form on your schedule, not ours.

We do not require insurance, our weight loss programs are affordable to make it convenient for you to pay

Semaglutide is a GLP-1 receptor agonist used for managing type 2 diabetes and for weight management. It mimics a hormone that helps regulate blood sugar and appetite.

 Tirzepatide is a newer injectable medication that works similarly to semaglutide but with a broader effect. It activates both the GLP-1 and GIP (Gastric Inhibitory Polypeptide) receptors to help control blood sugar and promote weight loss.

Both medications help lower blood sugar by increasing insulin secretion when blood sugar levels are elevated. They also slow gastric emptying, leading to reduced appetite and potential weight loss.

Semaglutide is approved for managing type 2 diabetes and for chronic weight management in adults with obesity or overweight (when combined with diet and exercise).

Tirzepatide is approved for managing type 2 diabetes and is also approved for chronic weight management in adults with obesity or overweight (similar to Semaglutide)..

Yes, it is approved for weight loss in individuals with obesity or overweight with related health issues

 Nausea, vomiting, diarrhea, and constipation are common side effects.

 It’s injected subcutaneously (under the skin) once a week.

 If you miss a dose, take it as soon as you remember, unless the next dose is due within 2 days.

 Yes, studies suggest it is safe for long-term use, but ongoing monitoring is recommended.

 If you miss a dose, take it as soon as you remember, unless the next dose is due within 2 days.

 Moderate alcohol consumption is usually fine, but excessive drinking should be avoided

 It typically does not cause low blood sugar unless used with other diabetes medications that lower glucose.

Yes, but consult your healthcare provider, especially if you're taking other diabetes medications or blood pressure medications. .

 People with a history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should avoid it.

 Yes, it improves insulin sensitivity, which may help with insulin resistance.

Blood sugar improvements may be seen within the first few weeks, but weight loss effects may take longer.

 Keep it in the refrigerator until use

Blood sugar improvements may be seen within the first few weeks, but weight loss effects may take longer.

No, Semaglutide is not addictive.

 Yes, it is approved for weight loss in people with obesity or related conditions.

 Side effects include nausea, diarrhea, vomiting, and decreased appetite